Adam Ang
The programme is being expanded to support patients living in rural and regional areas.
The approval marks its entry into the $160-billion US medical device market.
Also, Remidio receives a CE mark for its AI tool for detecting referable diabetic retinopathy.
Also, EpiSoft announces the integration of its cancer management platform with My Health Record.
Also, medical device unicorn Molbio has taken a 70% stake in digital x-ray manufacturer Prognosys.
They will offer online mental well-being support to AIA Singapore's corporate employee clients.
It will be based in Amsterdam, the Netherlands.
It seeks to use AI to improve the accuracy of an information-extracting method for structuring radiology reports.
Also, India has cleared the CardiacSense smartwatch for commercialisation.
Qure.ai's qXR software will enable Mylab's upcoming x-ray device to quickly detect TB.